How a New Treatment Could Help Fight Deadly Skin Cancer
Moderna’s mRNA Melanoma Vaccine: How a New Treatment Could Help Fight Deadly Skin Cancer Moderna’s experimental mRNA cancer vaccine is generating attention because of its potential role in fighting melanoma, the most dangerous form of skin cancer. Unlike traditional vaccines designed to prevent infections, this personalized treatment is designed to help the immune system recognize and attack cancer cells. The vaccine, known as mRNA-4157/V940 , is being developed by Moderna in partnership with Merck. It is being studied alongside Keytruda, an immunotherapy drug that helps the immune system attack certain cancer cells. SEE MORE.... How Does the Melanoma mRNA Vaccine Work? The treatment begins with an analysis of a patient's tumor. Scientists look for specific genetic changes, often called mutations, that may produce unique markers on the cancer cells. The personalized mRNA vaccine is then designed to teach the immune system to recognize these markers. The goal is to help immune ce...